InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Patel Chintu, Chairman & CEO. Officer active across 1 company, notably Amneal Pharmaceuticals, Inc.. In total, 4 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €367k. History available since 15 December 2021. The latest transaction was filed on 15 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
59,931 sharesClass A Common StockSEC:0001628280-26-015285:0
579,710 sharesClass A Common StockSEC:0001628280-25-010688:0
24,753,252 sharesClass A Common StockSEC:0001209191-23-054738:0
100,000 shares@ US$4.130.0096% mcap50.0% of flowClass A Common StockSEC:0001209191-21-070258:0
Canonical exit: 15 Mar 2022 (T+90)
4 of 4 declarations
About Patel Chintu
Chintu Patel is the Co-CEO of Amneal Pharmaceuticals, Inc. He leads the company with a focus on innovation and expansion in the pharmaceutical sector.
